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ABSTRACT  27 
Context Berries are a source of polyphenols with recognised health-promoting activities. Objective 28 
The aim of this systematic review is to provide evidence of short and long-term benefits of berries on 29 
vascular function. Data sources Human intervention studies were collected from PubMed and Scopus 30 
databases Data extraction After selection, 22 randomized-controlled trials were included and 31 
analyzed. Most of them were performed in healthy subjects or individuals with cardiovascular risk 32 
factors. Results The overall results seem to suggest a protective role of berries on vascular function 33 
even if dependent on time of exposure, type and dose of berry and biomarkers analysed. Flow 34 
mediated dilation and reactive hyperaemia index (markers of vascular reactivity) improved following 35 
short-term interventions, while pulse wave velocity and augmentation index (markers of arterial 36 
stiffness) only after medium-long term studies. Conclusions In conclusion, the current evidence 37 
suggests that berries, at physiological relevant doses, may have a role in the modulation of vascular 38 
function and stiffness. High-quality human intervention trials are encouraged in order to strengthen 39 
these findings and to better elucidate the mechanisms involved in such modulation.  40 
Keywords: berries; (poly)phenols; endothelial function; vascular function; intervention studies; 41 
systematic review 42 




Berries represent a wide group of blue, purple or red small-sized and highly perishable fruits. 45 
Blueberry, cranberry, currant, raspberry and blackberry are the most common varieties of berries 46 
consumed around the world1. Berries are an important source of (poly)phenols, including 47 
anthocyanins (ACNs), proanthocyanidins, flavonols, flavones, flavan-3-ols, flavanones, isoflavones, 48 
stilbenes, lignans and phenolic acids2,3.  49 
Berry consumption has been associated with a reduced all-cause mortality4. Moreover, in the last few 50 
years numerous epidemiological and clinical studies documented the protective effects of berries 51 
against many non-communicable chronic diseases, with some focusing on cardiovascular diseases 52 
(CVDs)5–7 which remain the leading causes of death worldwide8. The development of CVDs is often 53 
accompanied by a decline in vascular health and function. The endothelium represents an important 54 
part of the vasculature, by covering the inner surface of the blood vessels, and acting by controlling 55 
the flow of nutrients and non-nutrients, the passage of the fluids into the tissues, and the secretion of 56 
vasoactive substances, such as the vasodilator nitric oxide (NO) and vasoconstricting molecules like 57 
endothelin-1.  58 
Common biomarkers for the evaluation of vascular health include blood pressure (BP), arterial 59 
stiffness and vascular reactivity. Vascular reactivity can be assessed through endothelium-dependent 60 
(i.e. acetylcholine) or independent (i.e. nitroglycerin) mechanisms9,10. The main methods for vascular 61 
reactivity assessment are flow-mediated dilation (FMD) and peripheral arterial tonometry/reactive 62 
hyperaemia index (PAT/RHI). FMD is considered the gold standard non-invasive ultrasound 63 
technique, measuring vasodilation at the level of the brachial artery following a standard 64 
occlusion11,12. EndoPAT is a plethysmographic technique able to measure pressure changes in the 65 
finger tips caused by a 5 min occlusion of the brachial artery13. Among other measures, arterial 66 
stiffness can be measured through pulse wave velocity (PWV), which directly measures point-to-67 
point pulse wave transit time, and pulse wave analysis (PWA), which uses the pulsatile waveform 68 
shape to make assumptions about arterial haemodynamics. The stiffness can be also quantified 69 
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through the augmentation index (AIx), defined as the difference between the second and first systolic 70 
peak expressed as percentage of the pulse pressure14.  71 
Some systematic reviews and meta-analyses of observational and randomized controlled trials (RCT) 72 
reported a relationship between the consumption of polyphenols and polyphenol-rich foods and 73 
modulation of vascular function markers such as AIx, PWV, FMD and RHI15–17. Other direct and/or 74 
indirect biomarkers of vascular function include serum concentrations of inflammatory markers, 75 
adhesion molecules, lipids and lipoproteins, oxidized LDL-C, and clotting factors18. A meta-analysis 76 
of RCTs, performed by Huang et al.19, has shown that berry consumption may significantly reduce 77 
the levels of LDL-C, BP, fasting glucose, and tumour necrosis factor-α (TNF-) supporting their 78 
potential contribution on cardiovascular health.  79 
Based on these premises, the aim of this systematic review is to summarize the research findings of 80 
RCTs investigating the effect of berry consumption on markers of vascular function, in order to 81 
elucidate their potential role in CV health. The current systematic review exclusively focuses on 82 
studies (both acute and chronic interventions) performed with berries and berry products, 83 
differentiating it from other recent works.  84 
 85 
METHODS 86 
A systematic review was conducted according to the Preferred Reporting Items for Systematic 87 
Reviews and Meta-Analyses (PRISMA) statement20, and included all relevant PRISMA checklist 88 
items. A review protocol has not been published and this review has not been registered with any 89 
systematic review database. 90 
 91 
Eligibility Criteria (Inclusion and Exclusion Criteria) 92 
Studies were included in the present review if they investigated the effect of berry consumption on 93 
one or more markers of vascular function in humans. The studies present in literature had to adhere 94 
to the following criteria to be considered in the review process: i) to be randomised-controlled trials 95 
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that provided results on both acute (i.e. single dose supplementation) or chronic berry consumption 96 
and ii) to provide a characterization of the berry polyphenolic content. Conversely, exclusion criteria 97 
were: i) the presence of a combination of berries with other foods (because the beneficial effect could 98 
not be attributed specifically to berries) and ii) the fact of being published in a language different 99 
from English and with no accessible translation. No restrictions for the characteristics of subjects (e.g. 100 
age, gender, health condition) were considered. 101 
A more detailed list of criteria for eligibility in this systematic review has been summarized in 102 
Supplementary Table 1, by following the PICOS (Population, Intervention, Comparison, Outcome, 103 
Study design) format21. 104 
Search strategy and study selection 105 
A systematic literature search was conducted using PubMed (http://www.ncbi.nlm.nih.gov/pubmed), 106 
and Scopus (http://www.scopus.com) databases on December 2017 (updated October 2018). For 107 
completeness, searches were augmented by screening the bibliographies of relevant review articles.  108 
The search had no limit ranges for year of publication. Three search themes were considered: terms 109 
related to berry (e.g. strawberry, blueberry, cranberry) were combined with terms related to outcomes 110 
(e.g. pulse wave capacity, flow mediated dilation, arterial stiffness) and population type (e.g. human, 111 
volunteers, patients) to identify all potentially relevant literature published (further information on 112 
the search strategy in Appendix S1). No language or other restrictions were set in the literature search. 113 
The identification process is illustrated in Figure 1. 114 
 115 
Study selection and data collection process 116 
Two reviewers (MM and DM) independently abstracted data from studies eligible for inclusion. 117 
Disagreement between reviewers was resolved through consultation with a third independent 118 
reviewer (CDB) to reach a consensus. 119 
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The following data were extracted from each study: name of first author, country, registered trial 120 
number, sample size at recruitment and enrolment stages, inclusion/exclusion criteria, study design, 121 
dietary products used during the interventions, and vascular function outcomes. 122 
 123 
Risk of Bias in Individual Studies 124 
Risk of bias in individual studies and across the studies was assessed independently by two review 125 
authors (DA and DM) following the criteria of the Cochrane Handbook for Systematic Reviews of 126 
Interventions 5.1.022. The following parameters for each component’s rating were considered to 127 
produce the resulting scores: 1) Selection Bias. Sequence generation and allocation concealment; 2) 128 
Performance Bias. Blinding of participants and personnel; 3) Detection Bias. Blinding of outcome 129 
assessment; 4) Attrition Bias. Incomplete outcome data; 5) Reporting Bias. Selective reporting; 6) 130 
Other Bias. All the scores were assessed as “Low risk of bias”, “High risk of bias”, or “Unclear risk 131 
of bias” if insufficient details about these parameters were reported in the study22. All disagreements 132 
were resolved by consensus with a third review authors (CDB).  133 
Results 134 
Study selection 135 
The study selection process is shown in Figure 1. A total of 880 records were identified from the 136 
database search (PubMed and Scopus), while no additional papers were found by hand searching. 137 
After removing 179 duplicate articles, 701 studies were screened and 671 were discarded based on 138 
title and abstract. After the full-text reading of the remaining 30 eligible papers, a total of 9 records 139 
were further excluded were excluded because i) the study had no placebo/control food (n= 3), ii) 140 
berries were provided along with other food components (n= 1), iii) the fed products were not fully 141 
characterized for their (poly)phenol content (n= 5). At the end of the selection process, 22 RCTs were 142 
considered for qualitative analysis. 143 
Study characteristics 144 
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The main characteristics of the 22 included studies are reported in Tables 1 and 2. Out of these 22 145 
works, 11 dealt with acute interventions23–33and 9 with chronic interventions34–42, while 2 studies43,44 146 
investigated the effect of both acute and chronic berry consumption.  147 
The current review summarizes the main findings obtained evaluating the effect of different berries 148 
(mainly blueberries, cranberries, strawberries and blackcurrants) on vascular function. The berries 149 
were provided as raw fruits, drinks/smoothies, or extracts in capsules. The (poly)phenol content was 150 
dependent on the type of berry and on the administered portion (250-300 g for raw fruits, 250-1000 151 
mL/day for drink/smoothie and 600 mg for capsules). The main outcome variables measured were 152 
FMD and RHI for the vascular reactivity, and PWV and AIx for the arterial stiffness. 153 
 154 
Risk of bias of the studies  155 
Risks of bias within individual studies and across the studies are shown in Supplementary Figure 1 156 
and Supplementary Figure 2, respectively. Results showed the blinding of participants and 157 
personnel (performance bias) and blinding of outcome assessment (detection bias) to represent the 158 
highest risks of bias.  159 
 160 
Acute studies 161 
Table 1 reports the main results obtained in 13 short-term studies23-33,43,44 performed with berries on 162 
FMD (n=5), RHI (n=5) and other markers (n=3) of vascular function. Alqurashi and colleagues23 163 
have shown that the intake of 200 g of açai smoothie significantly increased FMD at 2 h (+1.4%; 164 
p=0.001) and at 6 h (0.8%; p<0.001) post-consumption in healthy overweight men. Similarly, 165 
Rodriguez-Mateos et al.32, found that the consumption of 3 pieces/buns of blueberry baked products 166 
and/or a blueberry drink (equivalent to 240 g of fresh blueberry) increased FMD after 1, 2, and 6 h 167 
from the intake. A significant improvement in FMD occurred after the consumption of the two items, 168 
at 1 h for the drink and 2 h for the baked products (up to +2.6%). In another study, the same authors 169 
reported that post-acute consumption of 5 cranberry juices (450 mL each) containing different 170 
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amounts of (poly)phenols (409, 787, 1238, 1534, and 1910 mg), significantly augmented FMD 1, 2, 171 
4, 6, and 8 h from the intervention33. FMD gradually increased in a time- (spiking at 4 h) and dose-172 
dependent manner, with maximum effect after the intake of 1238 mg total polyphenols (about +2.5%) 173 
While, Istas et al.29 showed that the intake of two different portions (200 and 400 g) of red raspberries 174 
(containing 201 or 403 mg of total polyphenols, respectively) improved FMD at 2 h (+1.6% and 175 
+1.2%, respectively) and 24h (+1.0% and +0.7%, respectively) in a group of 10 healthy subjects, so 176 
not finding a dose-response relationship.  177 
Regarding RHI, 3 studies reported a significant increase in this outcome measure. Del Bo’ et al.27 178 
found that 300 g of blueberries counteracted an impairment in RHI (−4.4 ± 0.8%, p<0.01) and 179 
improved Framingham (f) RHI (fRHI, +28.3 ± 19.2%, p<0.0001) in a group of healthy smokers with 180 
normal endothelial function (2 h post consumption). In another study, the authors documented that 181 
the same 300 g blueberry portion increased RHI values in smokers (+35.2 ± 7.5%, p=0.02) and in 182 
non-smokers (+54.8 ± 8.4%, p=0.01) with endothelial dysfunction26. Finally, Flammer et al.44 183 
observed a significant increase (p=0.01) in RHI (from 1.7 ± 0.4 to 2.0 ± 0.6; about +18%) at 1 h after 184 
cranberry juice consumption (2x 230 mL) in subjects with peripheral endothelial dysfunction and 185 
cardiovascular risk factors.  186 
Conversely, two studies did not report significant effects following short-term interventions with 187 
berries. Del Bo’ et al.28 showed that a portion of blueberry purée (300g) did not affect vascular 188 
reactivity, measured as RHI, after 1 h from the intake in a group of young healthy volunteers with 189 
normal peripheral arterial function (RHI>1.67) A similar result was also documented by Jin and 190 
colleagues30, following the intake of 250 mL of blackcurrant juice (20%), in a group of healthy 191 
subjects. The investigators measured vascular reactivity by laser Doppler imaging in response to 192 
acetylcholine (endothelial dependent) and sodium nitroprusside (endothelial independent), testing the 193 
effect after 2 h from the intake of the juice30. 194 
Regarding PWV and AIx, the studies included in this systematic review failed to observe any 195 




Chronic studies 198 
Table 2 shows the results obtained in 11 medium-long term interventions34-44 providing results on 199 
the effect of berries on markers of vascular function. Khan et al.38showed a significant increase 200 
(p=0.022) in FMD (from 5.8±3.1 to 6.9±3.1%; about +19%) after 6-week consumption of 201 
blackcurrant juice (1 L/day, providing 815 mg of total polyphenols) in healthy subjects. Similarly, 202 
Stull et al.41reported a significant improvement in RHI after a 6-week intake of two blueberry 203 
smoothies (45 g freeze-dried blueberry powder, providing about 800 mg total polyphenol) in 204 
subjects with metabolic syndrome. The results showed a greater effect of blueberry versus placebo 205 
(0.32 ± 0.13 versus −0.33 ± 0.14, respectively; p = 0.0023). On the other hand, 4 studies reported no 206 
significant effect on RHI or FMD35,39,43,44. Djurica et al.43 found that 1-week consumption of 50 g 207 
freeze-dried strawberry powder (equivalent to 500 g of fresh strawberries, with pelargonidin-3-208 
glucoside as main phenolic compound) did not improve RHI in overweight/obese adolescents. 209 
Flammer et al.44 showed that the intake of cranberry juice (2 × 230 mL/day) over 4 months had no 210 
effect on RHI in subjects with peripheral endothelial dysfunction and cardiovascular risk factors. 211 
Similarly, Riso et al.39 could not demonstrate an effect on RHI after a  6-week intervention with a 212 
wild blueberry drink (250 mL/day, providing 475 mg of anthocyanins) in subjects with 213 
cardiovascular risk factors. These results were consistent with Dohadwala et al.35 in which a 4-week 214 
cranberry supplementation (480 mL/day, providing 94 mg ACNs and 835 mg total polyphenols) did 215 
not affect FMD in subjects with coronary artery disease. 216 
With respect to arterial stiffness, 6 out of 7 studies showed a positive modulation of PWV and AIx 217 
following berry intervention. Feresin et al.36 reported that the intake of 240 mL of a strawberry drink 218 
(providing 25 g/day of freeze-dried powder, equivalent to approximately 1.5 cups of fresh 219 
strawberries) for 8 weeks significantly decreased brachial-artery pulse wave velocity (baPWV) and 220 
femoral-artery pulse wave velocity (faPWV) in pre- and stage 1-hypertensive postmenopausal 221 
women (−0.73 m s−1, p = 0.03 and −0.55 m s−1, p = 0.02, respectively). Similarly, Johnson et al.37 222 
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(2015) observed a significant reduction in baPWV  (from 1,498±179 cm/sec to 1,401±122 cm/sec; at 223 
about 6.5%; p<0.05) following 8-week consumption of a blueberry drink (providing 22 g/day of 224 
freeze-dried blueberry powder) in a comparable population. Dohadwala et al.35 documented a 225 
significant reduction in carotid-femoral pulse wave velocity (crPWV; from 8.3 ± 2.3 m/s to 7.8 ±2.2 226 
m/s; at about -6%; P=0.003), but not carotid-radial pulse wave velocity (cfPWV), after a 4-week 227 
intake of cranberry juice (480 mL/day) in subjects with coronary artery diseases. Significant findings 228 
were also documented for total peripheral resistance (TPR) and AIx. For example, 1-week 229 
consumption of New Zealand blackcurrant extract (600 mg/day) reduced TPR (-16%; p<0.05) in 230 
healthy males, both at rest and during exercise performance34. Similar results were also observed 231 
following 1-week intake of 6 g/day of New Zealand blackcurrant powder in well trained endurance 232 
athletes (TPR, -25%; P=0.003)42. Ruel et al.40 observed a decrease in AIx (−10.8% ± 6.4%; p<0.0001) 233 
following 4-week intervention with cranberry juice (500 mL/day, providing 400 mg of total 234 
polyphenols) in obese men, while Riso et al.39 reported no significant effect on AIx after 6-week 235 
intervention with wild blueberry drink (250 mL/day, providing 475 mg of anthocyanins) in subjects 236 
with cardiovascular risk factors.  237 
 238 
Potential risks of bias  239 
The highest risks of bias concerned blinding of participants as well as the blinding of the outcome 240 
assessment during the conduction of RCTs. For the latter, very few studies declared the non-241 
blindness, while in most studies personnel blinding was unstated. Allocation has been particularly 242 
considered and described in the various studies included in this review. There were high risks of bias 243 
when it was impossible to render the control undistinguishable from the berry product. Despite being 244 
randomized controlled trials, the randomization processes have been scarcely described in the papers, 245 
mainly due to poor or absent explanation of how the randomization was produced. However, it is 246 
worth to note that the blindness of the randomization process in dietary interventions is sometimes 247 
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difficult to achieve, due to the risk of an unbalanced allocation with consequent impact on data 248 
reliability.  249 
 250 
Discussion 251 
There is a clear interest in the exploitation of berries and derived products for their potential role in 252 
cardiovascular health, with a specific focus on vascular function. RCTs are considered the gold 253 
standard for ascertaining a causal relationship between intervention and effect of a treatment. The 254 
effect of polyphenol-rich foods in the modulation of vascular reactivity has been evaluated in several 255 
intervention studies but few systematic reviews and meta-analyses summarized their effects. In some 256 
cases, the effects were inconsistent for the measured markers of vascular function45–47. This 257 
discrepancy could be due to the inclusion of studies having heterogeneous characteristics and 258 
reporting high risk of bias. Moreover, most of the studies were focused on bioactives and bioactive-259 
rich foods in general, making the specific effects of berries very difficult to be identified. Conversely, 260 
the present review exclusively considered studies performed with berries and berry products, selected 261 
on the basis of quality criteria, and included only RCTs performed either in acute and chronic 262 
interventions. The complete picture obtained through this work points at an improvement in FMD 263 
and RHI (markers of vascular reactivity) following acute berry interventions. Some of the studies 264 
linked the observed effects to the increase in plasma circulating levels of berry bioactive 265 
constituents27 while  others by their circulating  gut/liver phenolic metabolites. 29  266 
Only one study showed a dose-response relationship between the intake of berries and vascular 267 
reactivity33 while  4 studies did not report significant effects following berry consumption24,28,30,43. 268 
These results may be due to the characteristics of the studied population (i.e. healthy individuals 269 
without specific risk factors and with normal endothelial function at basal levels). Moreover, matrix 270 
effect, potentially reducing the availability and/or impact of berry bioactives, small portions (even if 271 
more realistic) of berries, and time of evaluation/measurement of vascular function due to the rapid 272 
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clearance rate and poor absorbance of polyphenols may all have been diluting factors in the 273 
framework of the final evidence.   274 
An additional source of variability among acute studies can be related to the study protocol adopted 275 
and the characteristics of the test meals. Some studies provided berries and/or berry products (whole 276 
fruits or drink) alone or within/together with a high-fat23,31 or a high-carbohydrate meal24, and it is 277 
recognized that foods and food matrix may positively or negatively affect polyphenol 278 
bioavailability48. Moreover, the consumption of high-fat and/or high-carbohydrate meals may 279 
transiently increase post-prandial triglycerides and glycaemia with a negative effect on endothelial 280 
function49. These important variables/aspects could have affected the results obtained in the studies.  281 
Regarding the effects observed in medium-long term interventions, no clear favourable effects of 282 
berry products on vascular reactivity markers have been found, in line with the systematic review of 283 
Heneghan and coworkers50 that showed an effect only in 3 out of 7 studies. The discrepancy between 284 
short and long-term studies in terms of vascular reactivity (RHI and FMD) is intriguing and may be 285 
attributed to the complexity of the mechanisms involved in the maintenance of the vascular system 286 
function. For example, Dohadwala and coworkers35 reported that changes in nitric oxide mediated 287 
vascular reactivity can occur rapidly following a dietary intervention and this has been related to the 288 
“acute” absorption of food bioactives and/or their metabolites (e.g. able to directly/indirectly affect 289 
nitric oxide production). This underlines that necessarily critical factors affecting the evaluation of 290 
vascular function include the experimental design (e.g. in terms of timing of measurements), the 291 
targeted mechanism (e.g. nitric oxide production), and also the characteristics of the markers used to 292 
evaluate vascular reactivity. In fact, the markers available may provide different information 293 
depending on the study protocols (acute vs. chronic intervention). For example, short term studies 294 
can provide information on the direct modulatory effect of the absorbed bioactives (i.e. supporting 295 
biological plausibility) conversely, in the long term approach generally the exposure to the food 296 
bioactives is absent or limited (due to the active and rapid clearance of phenolic compounds even 297 
when consumed regularly). In this context, is not surprising the lack of effect underlined in chronic 298 
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studies where the measurement is performed about 12 h after the last intake of the bioactives. 299 
Moreover, the type of markers used may affect the results depending on the actual targeted 300 
measurement.  301 
Also the large heterogeneity of the enrolled groups of volunteers among the different RCTs (i.e. 302 
healthy subjects, individuals with cardiovascular risk factors or complications), also in terms of 303 
vascular function levels, could have affected the results obtained. Moreover, it cannot be excluded 304 
that the duration of the intervention was insufficient to exert a beneficial effect involving these 305 
specific target groups of population. An additional source of variability can be related to the form and 306 
the way through which berries have been provided. Some studies provided berries as raw fruit, others 307 
as a beverage, a smoothie, a sweet cake (i.e. muffins), alone or in combination with a meal. Moreover, 308 
berries could have been provided in addition to the habitual diet (resulting in an increased energy 309 
intake) or as substitutes of other foods normally consumed that are thus being displaced from the diet 310 
(isocaloric condition). The lack of the food that has been replaced may be important in determining 311 
the final effect on vascular function, although it is quite difficult to ascertain the magnitude. 312 
Moreover, the differences in berry administration may have played an important role in the results 313 
obtained, since the quality of a meal in terms of energy, macro and micronutrients intake may affect 314 
the vascular response. Also, considering that polyphenol intake may represent a confounding factor, 315 
subjects were often asked to maintain their usual diet and to refrain from the consumption of berries 316 
and other foods throughout the study period. Despite this, only few studies provided data about the 317 
actual dietary intake34,41 and the energy intake during the intervention and between treatments was 318 
rather constant. Conversely, no information about the actual intake of polyphenols was provided.  319 
Moreover, it is worth noting that the synergistic effects of other coexisting substances in berry foods 320 
such as vitamin C51, fiber52, potassium53 and magnesium54 may play a role in determining the 321 
improvement on vascular function.  322 
Arterial stiffness has been recognized as a determinant of pulse pressure and elasticity of the 323 
blood vessels. The loss of elasticity of the artery walls reduces its compensatory ability to absorb the 324 
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pulsatile energy and the wave propagation effects that influence peripheral wave reflection. This 325 
inability for compensatory response results in a gradual increase in blood pressure with age, leading 326 
to the development of isolated systolic hypertension and cardiovascular risk. Numerous intervention 327 
and observational studies have examined the relationship between polyphenols/polyphenol-rich foods 328 
and arterial stiffness. In a cross-sectional study, Jennings and colleagues15 showed that high intake of 329 
anthocyanins and flavones were inversely associated with low arterial stiffness (measured as PWV) 330 
across extreme quintiles of intake in women. Successively, Lilamand and colleagues17 assessed the 331 
relationship between flavonoids intake and arterial stiffness, measured as PWV, analysing 16 332 
intervention and 2 cross-sectional studies. Four intervention trials reported a significant decrease of 333 
arterial stiffness after a flavonoid-based intervention, while the observational studies showed a 334 
significant association between high flavonoid consumption and low arterial stiffness. A recent 335 
systematic review and meta-analysis of RCTs showed an improvement in arterial stiffness following 336 
anthocyanin supplementation47. The effects were more evident on PWV after acute intake, while the 337 
results on AIx were not univocal following both acute and chronic interventions. In the present 338 
systematic review, we documented that short-term interventions with berries failed to modulate PWV 339 
and AIx, as well as stiffness and reflation indexes (Table 1), in line, at least in part, with those previous 340 
observations. Conversely, medium-long term interventions suggest an improvement of these markers 341 
(Table 2), in accordance with results reported in the review of RCTs by Heneghan and coworkers50. 342 
A potential explanation of the different findings between short and medium/long term trials may be 343 
attributed to the type of subjects enrolled and to the duration of the treatment. In fact, the short-term 344 
interventions were performed in healthy subjects, and it is plausible that substantial variations in 345 
arterial stiffness over a short follow-up are unlikely to be observed in individuals without vascular 346 
dysfunction. In addition, also the type of marker analyzed (e.g. PWV versus AIx) and its high 347 
variability among subjects could have played a crucial role in the obtained results. It is noteworthy 348 
that most of the studies did not consider arterial stiffness as a primary outcome, and that the trials 349 
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were mostly underpowered for arterial stiffness evaluation. For this very reason, future studies should 350 
be specifically designed to ascertain the effect of berries on this specific marker. 351 
Strengths and limitations of the study 352 
Caution should be used when interpreting results or drawing conclusions on vascular effect of 353 
berries due to the high heterogeneity among studies in terms of type and dose of berries, 354 
administration source (i.e. whole fruit, juice drink or capsules), amount of provided polyphenols, and 355 
their bioavailability. Although the inclusion of different types of berries may represent a strength, the 356 
different composition of berries in terms of the type and quantity of phenolic compounds may be 357 
among the most important factors influencing the in vivo effects of berries on vascular function. It is 358 
well known that berry fruits contain different anthocyanin profiles55,56 and, for this reason, it is not 359 
always easy to compare study results because most of them differ for the referring standard 360 
compounds in anthocyanin intake, i.e. cyanidin- and peonidin-derivatives as major ACNs in 361 
cranberries, while pelargonidin predominates in strawberries6. Another weakness was the lack of 362 
good quality information about the bioavailability of anthocyanins and related metabolic products. 363 
Actually, after ingestion, anthocyanins metabolic fate is deeply influenced by pH and gut microbiota 364 
activities57. It is well ascertained that, similarly to other phenolic compounds, anthocyanins have a 365 
limited bioavailability, lower than 15%58. This is influenced by their interaction with several gut 366 
microbial strains and the subsequent phase II metabolism at enterocyte and hepatocyte level, leading 367 
to the production of several different metabolites, including phenylpropionic and phenylacetic 368 
acids58–60. A very limited number of studies provided information about the circulating amount of 369 
these metabolites in in vivo berry-related studies61. Moreover, it is not always easy to link the 370 
biological effects of berry consumption to anthocyanin gut microbial derivatives, as they are also the 371 
results of the degradation metabolism of several other phenolic compounds62. 372 
Other critical aspects are represented by the study design (acute versus chronic intervention and 373 
parallel versus crossover design), the duration of the intervention, subjects’ characteristics, and 374 
sample size. Most of the studies were performed on healthy subjects, so that the inclusion in the 375 
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analysis of trials involving volunteers with risk factors or diseases may have increased the 376 
heterogeneity of the results, making it difficult to draw any unequivocal conclusion. Moreover, some 377 
studies, despite being sufficiently powered, randomized and controlled, were performed in small 378 
groups of subjects and, for this reason, the results obtained have to be considered as preliminary and 379 
deserve further investigations.  380 
The use of different methods and the lack of standardized procedures and gold standard 381 
methodologies for the assessment of vascular function outcomes could be another potential critical 382 
point. For example, positioning of the cuff (upper versus lower arm), duration of brachial artery 383 
occlusion, and timing for the detection of peak hyperaemia still differ among investigators. This 384 
information is missing in the papers analysed, but it is clear that the different experimental conditions 385 
adopted may have had a role on the modulation of nitric oxide dependent and independent 386 
vasodilation mechanisms63, and affect the results obtained.   387 
Finally, it is important to underline that the search strategy applied in this systematic review excluded 388 
other direct and indirect markers of vascular function (e.g. circulating adhesion molecules, cytokines, 389 
interleukins, and blood pressure), which, in some studies, have been used to improve the 390 
understanding of the obtained results.     391 
 392 
Potential mechanisms of action involved in the modulation of vascular function  393 
One of the main hypothesized mechanisms of action of polyphenols consists of the activation of 394 
endothelial nitric oxide synthase (eNOS)/NO/cyclic guanosine mono phosphate (cGMP) signalling 395 
pathway involved in vasodilation. Once activated, NO stimulates soluble guanylate cyclase in the 396 
vascular smooth muscle cells by releasing cGMP, a second messenger, which induces the smooth 397 
muscle cells of the vessel to relax64,65. In addition, polyphenols have been shown to increase post-398 
prandial release of the active glucagon-like peptide 1, a major intestinal hormone that stimulates 399 
glucose-induced insulin secretion from β cells, upregulate endothelial nitric oxide synthase 400 
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expression and increase endothelial nitric oxide synthase phosphorylation, resulting in improved 401 
production of NO and thus endothelium-dependent relaxations66,67. 402 
Beside polyphenols, also insulin response may positively affect vascular function, since the binding 403 
to its receptor on endothelial cells seems to activate the eNOS pathway and, thus, the vasodilation 404 
process68. These processes are usually very fast and have been identified as potential mechanisms of 405 
action in the short-term studies. 406 
Other putative mechanisms through which polyphenols may affect vasodilation, in the short and 407 
medium-long term interventions, involved the regulation of vascular redox signalling. In this regard, 408 
berry components may activate nuclear factor E2-related factor 2-antioxidant/xenobiotic response 409 
element signalling pathway, which represents the major mechanism in cellular defence against 410 
oxidative and electrophilic stress64. Furthermore, polyphenols may modulate pro-inflammatory 411 
pathways by inhibiting reactive oxygen species and the redox-sensitive transcription of nuclear 412 
factor-kappa B, involved in gene expression of several pro-inflammatory cytokines, chemokines, 413 
adhesion molecules, inducible nitric oxide synthase, cyclooxygenase 2 and cytosolic phospholipase 414 
2, all playing an important role in the regulation of NO production and modulation of vascular 415 
function69.  416 
 417 
 418 
CONCLUSIONS  419 
In conclusion, despite the numerous limitations and confounding factors present in the reviewed 420 
studies, the overall results of this systematic review seem to suggest a potential positive effect of 421 
berries in the modulation of vascular function. In particular, the effects were observed for FMD and 422 
RHI in short-term studies and for PWV and AIx in medium-long term ones suggesting that differences 423 
in biomarker modulation may depend on the time of exposure to the dietary interventions and/or to 424 
the experimental protocol of the study. Future research using appropriate study designs that consider 425 
current knowledge gaps and combine the use of different biomarkers are consequently highly 426 
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recommended. Further RCTs in different and well characterized target groups of volunteers should 427 
be performed in order to strengthen the evidence on the efficacy of such treatments on vascular health 428 
and function, and perhaps to shed more light on the mechanisms underneath these effects. In this 429 
regards, studies on the structure-activity relationship of berry-polyphenols and/or their metabolic 430 
products could help understanding the potential mechanisms through which these compounds interact 431 
and positively affect the vascular system. Despite very difficult to estimate, most of the studies have 432 
shown an improvement of vascular function for doses of berries higher than 200 g (providing at least 433 
600-700 mg of total polyphenols). This data should be considered indicative and dose- and time-434 
dependent studies would be desirable to better identify the portion of berries (and related polyphenol 435 
amount) eliciting a beneficial effect on vasodilation. This information could be useful for the 436 
development of new products with vasoactive properties and possibly able to maintain vascular health 437 
and reduce the incidence of CVDs, also depending on identified target groups.  438 
 439 
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FIGURE CAPTIONS 655 
Figure 1. Flowchart of the study selection process 656 
 657 
Supplementary Figure 1. Risk of bias summary: review authors' judgments about each risk of bias 658 
item for each included study. 659 
 660 
Supplementary Figure 2. Risk of bias graph: review authors' judgments about each risk of bias item 661 
presented as percentages across all included studies. 662 
  663 
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Table 1. Characteristics of the study design, population, products, and outcomes of the considered acute intervention studies investigating the effect 664 




















n=23 healthy nonsmoker 
males (mean age 46 ± 1.9 
y; mean BMI 27.6 ± 0.4 
kg/m2)  
200 g of açai smoothie (AS, 
150 g acai pulp + 50 g banana) 
Composition per serving: 
Total Polyphenols 694 mg 
(493 mg ACN, 173.6 mg GA, 
9.6 mg quercetin, 9.3 mg 
CGA); Total carotenoids: 
179.3 mg 
200 mg control 
smoothie (CS) (50 g 
banana matched for fat) 
Composition per 
serving: Total phenolics 
<10 mg; Total 
carotenoids: 0 mg;  
FMD up to 6 h after 
consumption 
↑FMD at 2 h and 6 h 
after AS, but not CS 
consumption  
Castro-Acosta et 





n=22 subjects (13 M, 
mean age 45.4±13.7y, 
mean BMI 25.5±3.8 
kg/m2) 
200 mL of three different 
blackcurrant drinks 
Composition per 200 mL: 
Total phenolics: 460, 810 and 
1596 mg, respectively (total 
ACN 131, 322, 599 mg); 
vitamin C <0.5 mg 
Placebo drinks matched 
for astringency by 
adding tannins 
Composition per 200 
mL: Total phenolics 207 
mg (total ACN 46 mg); 
vitamin C <0.5 mg 
DVP-SI, DVP-RI up 
to 2h after 
consumption 
=DVP-SI and DVP-
RI compared to 
baseline for all 
blackcurrant and 
placebo drinks 





Study 1: n=12 
nonsmokers males with 
peripheral arterial 
dysfunction (mean age 
24.2±1.2y; mean BMI 
22.5±1.2 kg/m2) Study 2: 
n=12 smoker males, mean 
age 24.5±1.9y, mean BMI 
22.9±1.1kg/m2) 
Study 1: 300 g of thawed 
blueberry (BB) Study 2: 
blueberry treatment + smoking 
(BS) Composition per serving: 
Total phenolics 856 mg (309 
mg ACN, 30 mg CGA); 
Vitamin C: 2.4 mg 
Study 1: 300 mL of 
water matched for sugar 
(C) Study 2: Smoking 
(S); Smoking + Control 
treatment (SC) 
Composition: n.d. 
RHI, dAIx, dAIx@75 
2h after consumption 
Study 1: ↑RHI; 
=dAIx and dAIx@75  
Study 2: ↑RHI; 
=dAIx and dAIx@75 





n=16 healthy male 
smokers (mean age 
23.6±0.7y, mean BMI 
23.0±0.5kg/m2)  
300 g BB + smoking 
Composition per 100 g: Total 
phenolics 242.4 mg (116.1 mg 
ACN, 30.1 mg CGA), Vitamin 
C 0.8 mg 
1)  smoking   2) 300 mL 
of water with sugar + 
smoking Composition 
per 100 g: Total 
phenolics: 0 mg; 
vitamin C 0 mg 
RHI, fRHI, dAIx, 
dAIx@75 2h after 
consumption 
↑RHI and fRHI; 
=dAIx and dAIx@75 
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n=10 healthy nonsmoker 
males (mean age 20.8 ± 
1.6y, mean BMI 22.5 ± 
2.1 kg/m2) 
300 g of homogenized BB 
Composition per 100 g: Total 
phenolics: 242.4mg (30.1mg 
CGA, 116.1mg ACN); 
Vitamin C: 0.8 mg 
200 g Control Jelly (CJ) 
(20g of gelatine 
matched for sugars in 
200mL of water) 
Composition per 100 g: 
Total phenolics 0 mg; 
Vitamin C: 0 mg 
RHI by EndoPAT 1h 
after consumption 
= RHI after either BB 
or CJ consumption 






n=25 overweight or obese 
males (mean age 16 y; 
mean BMI: not clear)  
50 g of freeze-dried 
strawberry powder (FDSP) 
Composition per 50 g FDSP: 
pelargonidin-3-glucoside 
198.5 mg, 15.31 mg 
procyanidin B1, 12.52 mg 
catechin and other phenolics) 
50 g control powder 
(CP) matched for energy 
content and sugars 
Composition per 50 g: 
Total phenolics 0 mg 
RHI &fRHI by PAT 
1h after consumption 
= RHI and fRHI after 
either FDSP or CP 
consumption 







n=69 subjects with 
endothelial dysfunction 
and CV risk factors - 
Placebo group (n=37, 
11M, 2 smokers; mean 
age 51.4±15.1y, mean 
BMI 27.2±5.5 kg/m2) -
Cranberry juice (CBJ) 
group (n=32, 20M, 1 
smoker, mean age 
44.8±17.5y, mean BMI 
27.7±5.9 kg/m2) 
2x230mL CBJ Composition 
per mL: Total phenolics 1740 
μg (151 μg ACN, 2662 μg 
total proanthocyanidins) 
2x230 mL placebo 
beverage matched for 
sugars Composition per 
mL: Total phenolics n.d. 
RHI by EndoPAT 1h 
after consumption 
↑ RHI after either 
CBJ and placebo 
beverage, no 
difference between 
the two groups; =AIx 





double blind  
n=10 healthy males (mean 
age 27±3y, mean BMI 
23±2kg/m2) 
592 mL of drinks containing 
200 or 400 g of frozen 
raspberries in water. 
Composition per serving: 
Total polyphenols 201 and 
403 mg (164 and 328 mg 
ACN), Vitamin C 0.105 g  
592 mL of placebo 
drink matched for 
micro- and 
macronutrient to the 400 
g raspberry drink 
FMD up to 24 h after 
consumption 
↑FMD at 2h after 
consumption 







n=20 healthy subjects (11 
F/9 M, mean age 
44.5±13.3y, mean BMI 
23.81±2.46 kg/m2) 
250mL of 20% blackcurrant 
juice (BCJ) Composition per 
100 mL: 81.5 mg PAs, 12.2 
mg delphinidin, 8.0 mg 
cyanidin; Vitamin C 10.2 mg 
250mL of control drink 
Composition per 100 
mL: <10 mg PAs; 
Vitamin C: 0 mg 
LDI measures of 













independent) 2h after 
BCJ consumption 







overweight or obese 
subjects (13F, mean age 
28.1±2.7y, mean BMI 
31.4±0.8kg/m2; 17M, 
mean age 28.2±2.0y, 
mean BMI 
31.3±0.6kg/m2) 
40 g FDSP with a high-fat (50 
g total fat) meal Composition 
per 40 g: 158.76 mg 
pelargonidin-3-glucoside and 
other phenolics; Vitamin C 
229 mg 
40 g CP with a high-fat 
meal Composition per 
40 g: Total phenolics 
not available; Vitamin C 
0.196mg 
AP, Ai@75, PWV up 
to 4 h after the meal 
↓AP, Ai@75 after 
both FDSP and 
Cpcompared to 
baseline at 2 and 4 h    
=PWV  
Rodriguez-Mateos 





double blind  
n=10 healthy males (mean 
age 24±2y, mean BMI 
24±2 kg/m2) 
Five different CBJ 
Composition per serving: 
Total polyphenols 409, 787, 
1238, 1534, and 1910 mg, 
respectively (6.8-32.3 mg 
ACN; 14.5-76.9 mg flavonols; 
12.8-59.2 mg PAs) 
Control drink matched 




polyphenols 2.9 mg (2.7 
mg PAs) 
FMD (%), PWV 
(m/s), AIx (%) up to 
8 h after consumption 
↑FMD at 1,2 4 6 and 
8 h after consumption 
(max at 4h) with 
maximal effects for 
the drink containing 
1238 mg total 
polyphenols; =AIx 
and PWV  
Rodriguez-Mateos 





n=10 healthy males (mean 
age 27 ± 1y, mean BMI 
25 ± 0.8 kg/m2) 
 a) Three baked products 
containing 34 g BB powder in 
(BB bun) Composition per 
bun x3: Total polyphenols: 
637 mg (196 mg total ACN, 
140 mg total procyanidins, 
221 mg CGA) b) 34 g BB 
powder dissolved in 500 mL 
water (BB drink) Composition 
per 500 mL: Total 
polyphenols: 692 mg (339 mg 
total ACN, 111 total 
procyanidins, 179 mg CGA)  
Control baked products 
(control bun) matched 
for macro and 
micronutrients 
Composition: n.a. 
FMD up to 6 h after 
consumption 
↑FMD at 1, 2 and 6h 
after consumption 
(max at 1h for BB 
drink and at 2h for 
BB bun) 
Rodriguez-Mateos 





Study 1:  n=10 healthy 
males (mean age 27 ± 
1.3y, mean BMI 25±0.8 
kg/m2)      Study 2:  n=11 
healthy males (mean age 
Study 1: three different BB 
drinks Composition per 
serving: total polyphenols  
766, 1278, and 1791 mg (310-
724 mg ACN; 137-320 mg 
procyanidin; 273-637 mg 
Studies 1 and 2: Control 




Study 1: FMD; PWV; 
AIx; DVP up to 6 h 
after consumption 
Study 2: FMD 1 h 
after consumption 
Study 1: ↑FMD but 
not at 4 h; =PWV; 
AIx; DVP; Study 2: 
↑FMD dose-




27 ± 1.0y, mean BMI 
22±0.9 kg/m2)  
CGA); Vitamin C 4-9.5 mg 
Study 2: five different BB 
drinks  Composition per 
serving: total polyphenols  
319, 639, 766, 1278, and 1791 
mg (129-727 mg ACN; 57-
320 mg procyanidin; 114-637 
mg CGA); Vitamin C 1.7-9.5 
mg 
polyphenols 0 mg; 
Vitamin C: 6.8 mg 
       
       
Legend: ACN: anthocyanins; AIx: augmentation index; AP: augmentation pressure; AS: açai smoothie; BB: blueberry; BCJ: blackcurrant juice; BMI: 666 
body mass index; BS: blueberry + smoking; C: control; CBJ: cranberry juice; CGA: Chlorogenic acid; CJ: control jelly; CP: control powder; CS: 667 
control smoothie; CV: cardiovascular; dAIx: digital augmentation index; dAIx@75: dAIx normalized by considering a heart rate of 75 bpm; DVP: 668 
digital volume pulse; F: females; FDSP: freeze dried strawberry powder; FMD: flow mediated dilation; fRHI: Framingham reactive hyperaemia index; 669 
GA: gallic acid; LDI: laser Doppler imaging; M: males; PAs: phenolic acids; PAT: peripheral arterial tonometry; PWV: pulse wave velocity; RHI: 670 
reactive hyperaemia index; RI: reflection index; S: smoking; SC: smoking + control; SI: stiffness index. 671 
 672 
  673 
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Table 2. Characteristics of the study design, population, products, and outcomes of the considered chronic intervention studies investigating the effect 674 






















n = 13 healthy males 
(mean age 25±4 y; mean 
BMI 25±3 kg/m2) 
1 week 
600 mg/day (2 x 300 mg 
capsule) of New Zealand 
blackcurrant (NZBC) extract 
Composition per capsule: 105 
mg ACN 
600 mg/day (2 × 
300 mg capsule) of 
cellulose 




resistance at rest 





and 120 s 






n=25 overweight or 
obese males (mean age 
16 y; mean BMI: not 
clear)  
1 week 
50 g/day of freeze-dried 
strawberry powder (FDSP) 
Composition per 50 g: 
Pelargonidin-3-glucoside 
198.5 mg, 15.31 mg 
Procyanidin B1, 12.52 mg 
Catechin and other phenolics) 
50 g control 
powder (CP) 
matched for energy 
content and sugars 
Composition: Total 
phenolics 0 mg 
RHI &fRHI by 
PAT 
= RHI and fRHI 
after either FDSP or 
CP consumption 







n=44 subjects with stable 
coronary artery disease -
CBJ first, n=22 (15 M, 
mean age 61±11y; mean 
BMI 30±5 kg/m2) - 
Placebo (PJ) first, n=22 
(15 M, mean age 63±9y, 
mean BMI 29±4 kg/m2) 
4 weeks 
480 mL/day cranberry juice 
(CBJ) Composition per 
serving: Total polyphenols 
835 mg (94 mg ACN) 
480 mL/day PL 
juice drink matched 










PWV after CBJ = 
FMD (upper arm), 
lnPATratio, 
carotid-radial PWV   







females with pre- or 
stage-1 hypertension  -
Control group, n=20 
(mean age 58±1y, mean 
BMI 32.1±0.7kg/m2) - 
Intervention group 1, 
n=20 (mean age 61 ±1y, 
BMI 31.0±1.0 kg/m2) - 
8 weeks 
Intervention group 1: 25 g/day 
FDSP + 25 g/day of placebo 
powder Intervention group 2: 
50 g/day of FDSP 
Composition per 25 g FDSP: 
99.22 mg pelargonidin-3-
glucoside, 7.70 mg 
procyanidin B1, 6.26 mg 
catechin and other phenolics 
50 g of PL powder 
Composition: Total 






ankle PWV after 25 





Intervention group 2, 
n=20 (mean age 59±1y, 
mean BMI 32.7±1.1 
kg/m2)  







n=69 subjects with 
endothelial dysfunction 
and CV risk factors - 
Placebo group, n=37 
(11M, mean age 
51.4±15.1y, mean BMI 
27.2±5.5 kg/m2) - 
Cranberry juice (CJ) 
group, n=32 (20M, mean 
age 44.8±17.5y, mean 
BMI 27.7±5.9 kg/m2) 
4 months 
2x230mL CBJ Composition 
per mL: Total phenolics 1740 
μg (151 μg total ACN, 2662 
μg total proanthocyanidins) 





= RHI after either 
CBJ and PL, no 
difference between 
the two groups 






n=48 light smoker 
subjects with pre-
hypertension - 
Intervention group, n=25 
(mean age 59.7±4.58y, 
mean BMI 30.1±5.94 
kg/m2) -Placebo group, 
n=23 (mean age 
57.3±4.76y, mean BMI 
32.7±6.5 kg/m2) 
8 weeks 
22 g/day of freeze-dried BB 
powder Composition per 
serving: Total phenolics 
844.58 mg (469.48 mg ACN), 





phenolics 0 mg, 


















n= 66 healthy subjects -
Placebo group, n= 21 (15 
M, mean age 51±8y; 
mean BMI 28.9 ± 
6.5kg/m2) - Intervention 
group 1, n=22 (15 M, 
mean age 55±10y, mean 
BMI 28.4 ± 5.4kg/m2) - 
Intervention group 2, 
n=21 (13 M, mean age 
51±11y; mean BMI 29.2 
± 6.9 kg/m2)   
6 weeks 
- Intervention group 1: 1 
L/day low blackcurrant juice 
(BCJ, 4 x 250 mL) 
Composition per 100 mL: 
Total polyphenols 27.3 mg (4 
mg ACN), vitamin C 1.1 mg       
 - Intervention group 2: 1 
L/day high BCJ (4 x 250 mL) 
Composition per 100 mL: 
Total polyphenols 81.5 mg 
(14.3 mg), vitamin C 10.2 mg  
1 L of flavored 
water (4x250 mL) 
Composition: n.d. 
FMD 
↑FMD after high 
BCJ, but not after 
low BCJ, compared 
to placebo 





n=18 healthy males with 
one risk factor for CVD 
(mean age 47.8±9.7y, 
mean BMI 24.8±2.6 
kg/m2) 
6 weeks 
250 mL/day Wild BB drink 
(25g of BB powder in 250 mL 
of water) Composition per 25 
g powder: 375 mg ACN, 
127.5 mg CGA  





RHI, fRHI, AIx, 
AI@75 
=RHI, fRHI, AIx, 
AI@75 






n=35 healthy overweight 
men (mean age 45±10y, 
mean BMI 28.3 ± 2.4 
kg/m2) 
4 weeks 
500 mL/day CBJ (4x125mL) 
Composition per 500 mL: 
Total polyphenols 400 mg 
(20.8 mg ACN, 296 mg 






500 mL: Total 
polyphenols 156 
mg (20.8mg ACN, 
296 mg 
proanthocyanidins), 
vitamin C 128 mg 





= resting AIx, AIx 
salbutamol, AIx 
GTN and global 
endothelial 
function after CBJ 
compared to 
placebo, but ↓ 
within-group 
resting AIx, AIx 
salbutamol and 
global endothelial 
function  after CBJ, 
and ↓ within-group 




subjects with MetS 
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n=44 non-smokers with 
MetS - Intervention 
group, n=23 (11 M, 
mean age 55±2y, mean 
BMI 35.2±0.8kg/m2) -
Placebo group, n=21 (5 




Two smoothies /day  (2 x 12-
oz yogurt and skim milk-
based smoothie with 22.5 g of 
freeze-dried BB powder) 
Composition per smoothie: 
Total phenolics 773.6 mg 
(290.3 mg ACN), vitamin C 
2.7 mg 
Two smoothies 
/day  (2 x 12-oz 







vitamin C 0 mg 
RHI 










n=13 triathletes (8 M, 
mean age 38±8y, mean 
BMI 23±2 kg/m2) 
1 week 
6 g/day Sujon NZBC 
dissolved in water 
Composition per serving: 
138.6 mg ACN, vitamin C 49 
mg 
250 mL/day BCJ 
Composition per 
serving: 3-4 mg 




↓ total peripheral 
resistance after 
NZBC compared to 
control (-16%) 
Legend: ACN: anthocyanins; AIx: augmentation index; AIx@75: AIx normalized by considering a heart rate of 75 bpm; BB: blueberry; BCJ: 676 
blackcurrant juice; BMI: body mass index; CBJ: cranberry juice; CGA: Chlorogenic acid; CP: control powder; CV: cardiovascular; CVD: 677 
cardiovascular disease; F: females; FDSP: freeze dried strawberry powder; FMD: flow mediated dilation; fRHI: Framingham reactive hyperaemia 678 
index; GTN: glyceryl trinitrate; lnPAT: natural logarithm of the peripheral arterial tonometry index; M: males; MetS: metabolic syndrome; NZBC: 679 
New Zealand blackcurrant; PJ: placebo juice; PL: placebo; PWV: pulse wave velocity; RHI: reactive hyperaemia index. 680 
  681 
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  723 
Full-text article excluded (n = 12) 
- No placebo/control (n = 3) 
- Food not characterized for its 
(poly)phenol content (n = 4) 
- Not original (n = 1) 
- Proceedings / Abstract (n = 2) 










Records identified through 
database searching (n = 880): 
- PubMed (n = 600) 






















Records screened  
(n = 757) 
Records of full-text assessed for 
eligibility  
(n = 34) 
Records excluded based on title or 
abstract (n = 723) 
 
Records included in the 
qualitative analysis  
(n = 22) 
Records after duplicates removed 
(n = 757) 
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21. Lichtenstein AH, Yetley EA, Lau J. Application of systematic review methodology to the field of 728 
nutrition. J Nutr. 2008;138:2297-2306 729 
  730 
Parameter Criteria 
Population (P) 
Not hospitalized children, adolescents or adults, regardless of the age, BMI 
and health/pathological status. 
Intervention (I) 
Dietary intervention studies involving the consumption of berries, 
regardless of the supplied form (raw, juices, supplements, etc.), not in 
combination with other foods which may overlap the effects. 
Comparison (C) 
Control group (berries totally or partially excluded, totally or partially 
substitute with other fruits/supplements). 
Outcome (O) 
Endothelial dysfunction, such as RHI (Reactive Hyperaemia Index), Aix 
(Augmentation index), PWV (Pulse Wave Velocity) and FMD (Flow 
Mediated Dilation). 
Study design (S) 
Inclusion:  Randomized controlled trials 
Exclusion:  Non-randomized controlled trials;  Retrospective, prospective,  




Supplementary Figure 1 731 
 732 
  733 
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Supplementary Figure 2 734 
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